These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34094957)

  • 1. Regulation of ERα Stability and Estrogen Signaling in Breast Cancer by HOIL-1.
    Ding J; Kuang P
    Front Oncol; 2021; 11():664689. PubMed ID: 34094957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
    Yuan L; Li X; Yang H; Li H
    Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of estrogen receptor α by USP37 contributes to the progression of breast cancer.
    Cao J; Wang X; Wang S; Chen Z; Tang J
    Cancer Sci; 2023 May; 114(5):2041-2052. PubMed ID: 36221793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
    Xia X; Huang C; Liao Y; Liu Y; He J; Shao Z; Hu T; Yu C; Jiang L; Liu J; Huang H
    Cell Death Dis; 2021 Mar; 12(4):329. PubMed ID: 33771975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
    Zhuang T; Yu S; Zhang L; Yang H; Li X; Hou Y; Liu Z; Shi Y; Wang W; Yu N; Li A; Li X; Li X; Niu G; Xu J; Hasni MS; Mu K; Wang H; Zhu J
    Oncotarget; 2017 Sep; 8(44):77137-77151. PubMed ID: 29100376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The deubiquitinating enzyme USP1 modulates ERα and modulates breast cancer progression.
    Niu Z; Li X; Feng S; Huang Q; Zhuang T; Yan C; Qian H; Ding Y; Zhu J; Xu W
    J Cancer; 2020; 11(23):6992-7000. PubMed ID: 33123289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
    Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
    Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM8 inhibits breast cancer proliferation by regulating estrogen signaling.
    Tian Z; Tang J; Liao X; Gong Y; Yang Q; Wu Y; Wu G
    Am J Cancer Res; 2020; 10(10):3440-3457. PubMed ID: 33163282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
    Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
    Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer.
    Ciupek A; Rechoum Y; Gu G; Gelsomino L; Beyer AR; Brusco L; Covington KR; Tsimelzon A; Fuqua SA
    Breast Cancer Res Treat; 2015 Nov; 154(2):225-37. PubMed ID: 26487496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells.
    Yang H; Lv X; Li X; Mao L; Niu Z; Wang T; Zhuang T; Huang Q
    Front Oncol; 2021; 11():638751. PubMed ID: 33777799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.
    Yu S; Gong X; Ma Z; Zhang M; Huang L; Zhang J; Zhao S; Zhu T; Yu Z; Chen L
    Cell Oncol (Dordr); 2020 Feb; 43(1):65-80. PubMed ID: 31701491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer.
    Tecalco-Cruz AC; Ramírez-Jarquín JO
    World J Clin Oncol; 2018 Aug; 9(4):60-70. PubMed ID: 30148069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR.
    Lu R; Hu X; Zhou J; Sun J; Zhu AZ; Xu X; Zheng H; Gao X; Wang X; Jin H; Zhu P; Guo L
    Nat Commun; 2016 Jul; 7():12044. PubMed ID: 27375289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-ADP-Ribosylation of Estrogen Receptor-Alpha by PARP1 Mediates Antiestrogen Resistance in Human Breast Cancer Cells.
    Pulliam N; Tang J; Wang W; Fang F; Sood R; O'Hagan HM; Miller KD; Clarke R; Nephew KP
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30621214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sesterterpene MHO7 suppresses breast cancer cells as a novel estrogen receptor degrader.
    Zhao Y; Zhao C; Lu J; Wu J; Li C; Hu Z; Tian W; Yang L; Xiang J; Zhou H; Deng Z; Huang J; Hong K
    Pharmacol Res; 2019 Aug; 146():104294. PubMed ID: 31175940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
    Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
    Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cells.
    Herynk MH; Beyer AR; Cui Y; Weiss H; Anderson E; Green TP; Fuqua SA
    Mol Cancer Ther; 2006 Dec; 5(12):3023-31. PubMed ID: 17172405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.